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INTRODUCTION: Complement activation occurs second-
ary to a variety of external stimuli. Lactic acidosis has
been previously  shown to  activate  the complement
factors C3a and C5a. In the present investigation we
examined the differential effect of lactic acidosis on
anaphylatoxin  levels  in  cord  and  adult  blood.  Fur-
thermore we aimed to determine if the entire comple-
ment cascade could be activated by lactic acidosis.
Methods: Cord and adult blood samples (n = 20 each)
were collected and incubated for one hour in either
untreated condition or with the addition of lactate in
two  concentrations  (5.5mmol/l  vs 22mmol/l).  Fol-
lowing incubation, levels of C3a, C5a and sC5bÐ9, and
blood gas parameters were determined.
Results:  Anaphylatoxin  (C3a  and  C5a)  and  sC5bÐ9
levels increased with the addition of lactate in a dose-
dependent manner in cord and adult blood (C3a: 1h,
5.5mmol/l,  22 mmol/l:  418/498/622 m g/l  in  cord
blood;  1010/1056/1381 m g/l  in  adult  blood,  p<0,05;
similar results were found for C5a and sC5bÐ9).
Conclusion:  Lactic  acidosis  leads to  an activation  of
the  entire  complement  system  in  neonates  and  in
adults.  This  activation  is  dose-dependent and  more
pronounced in adults as compared to neonates.
Key  words:  Lactate,  Cord  blood,  Adult  blood,  Comple-
ment, Activation, Anaphylatoxins
Introduction
Activation of the complement system occurs due to a
variety of conditions. These are either associated with
hypoxia or with cellular damage resulting in acidosis
during conditions like birth asphyxia or infection.1–4
The  components of  damaged tissue  like  mitochon-
drial fractions or other subcellular components cause
activation  of  complement  via  the  alternative  path-
way.5,6 As we have shown previously, lactic acidosis
itself  can  result  in  activation  of  C5a  even  in  the
absence  of  cellular  components.7 The  aim  of  this
study was to investigate whether lactic acidosis led to
an activation of the entire complement cascade and to
look  for  differences  in  complement  activation
between neonatal and adult blood. Furthermore we
aimed  to  determine  whether  anticoagulation  with
heparin or citrate led to different levels of activation
of the complement system.
Materials and methods
Following informed consent, blood samples of 10ml
were  collected  in  polypropylene  tubes  from  the
placenta of 20 term newborns without acidosis (base
excess<–10)  and  20  healthy  adult  volunteers.  Each
specimen was devided into two samples of 5ml and
either 100 units of heparin or 0.5ml sodium-citrate
was  added  for  anticoagulation.  Four  5ml  samples
(heparin-placenta-blood,  citrate-placenta-blood,  hep-
arin-adult-blood, citrate-adult-blood) were devided in
3 portions and remained untreated, were treated with
lactate  0.5mg  (5.5 m mol/l)  or  with  lactate  2mg
(22 m mol/ml). Samples were incubated for 60min at
37°C.  Following  incubation  1mg  disodium-ethylen-
diaminetetra-acetic-acid  was  added  to  the  heparin
samples to stop complement activation and samples
were  centrifuged  immediately.  The  remainder  was
stored at –80°C. Blood pH, potassium, lactate concen-
tration, pCO2, and base excess were measured in all
samples prior to and following incubation. C5a and
C3a were quantified by the use of a specific sandwich
enzyme immuno assay (Behring, Marburg, Germany).
The terminal complement complex was measured by
the Elisa technique detecting the soluble sC5b–9 (LD
Labordiagnostik, Heiden, Germany).
Statistical analysis
As most data were not normally distributed, results
were  expressed  as  medians  with  quartiles.  Differ-
ences  between  placental  and  adult  samples  were
assessed by the Wilcoxon test. Statistical significance
was assumed at p<0.05. All calculations and tests were
performed with the SPSS-PC-Software 9.0  (Chicago,
IL, USA).
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Baseline  levels  of  pH  were  not  different  between
umbilical  cord (7.34  [7.30/7.38])  and  adult  venous
blood (7.36 [7.35/7.37]). Base deficit (BE) and lactate
were significantly higher in neonatal blood (for details
see Table 1).
Incubation induced significant changes of pH, base
deficit and lactate in both placental and adult blood
samples  (pH:  cord  blood:  7.34  at  0h  to  7.28
[7.24/7.31] at 1h, p<0.05; adult blood: 7.36 to 7.34
[7.32/7.36],  p<0.05;  for  details  of  base  deficit  and
lactate  see  Table  1).  Lactate  concentrations  were
higher in placental blood during all conditions when
compared  to  adult  blood  (for  details  see Table  1).
Levels of potassium were higher in cord blood (data
not  shown)  as  was  the  base  deficit  (Table  1).
Anaphylatoxin  (C3a  and  C5a)  and  sC5b–9  levels
increased from  baseline incubation with  more pro-
nounced acidosis and showed substantial differences
between  placental  blood  and  adult  blood:  comple-
ment factors were significantly higher in adult blood
(Table 2).
Anticoagulation with citrate rather than heparin did
not affect levels of lactate nor base deficit (data not
shown). The use of citrate decreased baseline levels of
pH (cord blood: 7.29 [7.25/7.34] vs7.34, p<0.05; adult
blood: 7.32 [7.31/7.34] vs 7.36, p<0.05). Whereas C3a
levels were higher in adult samples when treated with
heparin  (C3a:  1010 m g/l  [882/1148;  heparin]  vs
704 m g/l  [292/978;  citrate],  p<0.05),  no  significant
differences existed in cord blood samples. Levels of
C5a  were  different  in  cord  blood  samples  (C5a:
0.23 m g/l  [0.119/0.401;  heparin]  vs 0.646 m g/l
[0.314/1.077; citrate], p<0.05), but did not differ in
adult blood specimens (for details see Table 3).
Discussion
In the present investigation we provide evidence of
activation  of  the  entire  complement  cascade  by
exposure to lactic acid. Baseline complement levels
were lower in neonatal as compared to adult blood,
activation of complement occurred in a dose-depend-
ent  manner  and  was  less  pronounced  in  neonatal
blood.
F. Hecke et al.
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Table 1. Base deficit and lactate concentration for cord and adult blood at 0h, 1h, and after equilibration with lactate (5.5mmol/l
and 22mmol/l)
Cord blood
median P25 P75
Adult blood
median P25 P75
Significance
Base deficit
0h 8.35 7.03 9.35 3.70 2.30 4.65 p<0.05
1h 10.10 9.00 11.10 4.75 3.85 6.20 p<0.05
5.5mmol/l 15.80 13.83 17.05 10.85 8.43 11.88 p<0.05
22mmol/l 29.25 26.60 31.42 25.25 22.82 27.35 p<0.05
Lactate [mmol/l]
0h 3.30 2.40 3.88 1.02 0.82 1.18 p<0.05
1h 5.12 4.36 5.51 2.70 2.34 3.23 p<0.05
5.5mmol/l 10.53 8.66 11.68 7.80 7.26 8.95 p<0.05
22mmol/l 21.22 14.45 23.97 18.21 13.75 24.56 n.s.
Table 2. C3a, C5a and sC5b–9 in untreated cord and adult blood at 1h and after equilibration with lactate (5.5mmol/l and
22mmol/l)
Cord blood
median P25 P75
Adult blood
median P25 P75
Significance
C3a [m g/l]
1h 418 182 560 1010 882 1148 p<0,05
5.5mmol/l 498 240 640 1056 865 1343 p<0,05
22mmol/l 622 243 922 1381 1033 1604 p<0,05
C5a [m g/l]
1h 0.230 0.119 0.401 0.969 0.605 1.199 p<0,05
5.5mmol/l 0.331 0.116 0.566 1.123 0.232 2.609 p<0,05
22mmol/l 0.650 0.753 1.870 2.458 1.437 4.236 p<0,05
SC5b–9 [m g/l]
1h 110 72 173 270 220 358 p<0,05
5.5mmol/l 289 217 380 437 366 556 p<0,05
22mmol/l 406 274 590 589 492 717 p<0,05T
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Lactate activates complement
Mediators of Inflammation · Vol 10 · 2001 29We  have  previously  shown  that  lactic  acidosis
activates complement and contact system in blood of
healthy  adult  volunteers.8 Furthermore  we  estab-
lished reference values for healthy term newborns in
umbilical  cord blood.9 In  subsequent  investigations
we could demonstrate that acidosis itself rather than
lactate  triggered  the  activation  of  the  complement
components C3 and C5 in healthy adult volunteers.7
We now provide evidence that complement activa-
tion  in  neonatal blood  is  less  readily  achieved and
results in lower levels as compared to those in adult
blood.  Furthermore  we  show  that  lactic  acidosis
initiates the entire cascade of complement factors in
neonatal and adult blood.
Lactate, which is the final product of the anaerobic
metabolism, reflects the degree of hypoxia in periph-
eral  tissues.  Early  hyperlactatemia  in  critically  ill
children has been shown to be associated with a high
mortality.10 During septic shock in adults the predic-
tion of multiple organ failure is feasible on the basis of
serial blood lactate determinations.11 Serial measure-
ments of lactate in  ventilated neonates revealed an
association between raised lactate levels and mortal-
ity.12 In addition there is evidence that neonatal base
deficit or pH cannot be used as a proxy measure of
serum lactate due to higher levels of base deficit and
lower  pH  levels  in  newborn blood.12 These results
confirm our findings of higher levels of lactate and
base  deficit  and  a  lower  pH  in  cord  blood  as
compared to adult blood.
Complement activation has been demonstrated in a
variety  of  neonatal  conditions  such  as  early  onset
infection,13 respiratory distress syndrome14 and peri-
natal  asphyxia.15 Elevation  of  serum  lactate  is  a
common event during the course of these neonatal
diseases. The fact that lactic acidosis leads to comple-
ment  activation  in  neonatal  blood  has  not  been
demonstrated previously, comparable data only exist
for adult blood.7 In addition we have shown that the
complement  cascade  is  activated  right  through  to
sC5b–9, which indicates that lactic acidosis is capable
of initiating an inflammatory response via activation
of complement. Coactivation of complement factors
and  proinflammatory  cytokines like  IL–6  has  been
shown by other investigators during cardiopulmonary
bypass.16 Similar data exist for IL–1, tumor necrosis
factor  (TNF-a ),  oxygen-derived  free  radical  genera-
tion, and complement activation during extracorpor-
eal  membrane  oxygenation.17 Whether  these  acti-
vated mediators or their target cells ultimately lead to
cellular damage depends on various factors including
the energy status of the cells exposed. A rodent model
of  CNS  trauma  demonstrated  only  recently  that
inflammatory  processes alone are  able  to  initiate  a
cascade of secondary tissue damage, which resulted
in  progressive  cavitation  and  glial  scarring  in  the
CNS.18 Potential mediators of the associated inflam-
matory  activation  were  fibrinogen,  factor  X,  and
complement  protein  iC3b. Taken together,  there is
evidence for a co-activation of several inflammatory
mediators  by  the  initial  event  of  lactic  acidosis.
Activation  of  this  inflammatory  cascade  may  ulti-
mately lead to tissue damage, which may or may not
be organ-specific. Clearly further research is required
in  order  to  clarify  mechanisms  of  activation  and
thereby  point  out  potential  therapeutic
interventions.
Anticoagulation  of  blood  drawn  for  complement
studies is usually performed with heparin due to the
interference  of  EDTA  and  citrate-related  calcium
binding with complement assays.19 Results of a recent
investigation suggest that citrate inhibits complement
activation in a dose-dependent manner, which implies
that citrate levels below a certain threshold may not
interfere  with  the  complement  system.20 In  our
investigation  anticoagulation  with  citrate  did  not
influence  levels  of  complement  in  a  uniform  and
reproducible manner. Until the interference of citrate
levels with the quantification of complement levels is
further clarified, we cannot recommend the use  of
citrate for these investigations.
Conclusion
Lactic acidosis triggers activation of the entire com-
plement cascade in neonatal as well as in adult blood,
although  less  so  in  neonatal  blood. Anaphylatoxin
concentrations (C3a, C5a) and levels of the comple-
ment  activation  product  sC5b–9  increase  during
incubation  in  a  time-  and  dose-dependent  manner
with  more pronounced lactic  acidosis. Anticoagula-
tion with citrate results in unpredictible modulations
of  complement  factors  and  should  be  avoided  for
laboratory evaluation of the complement status.
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